Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9O54

ADAM17 Prodomain-Metalloproteinase Domains bound to MEDI3622 Fab

Summary for 9O54
Entry DOI10.2210/pdb9o54/pdb
EMDB information70123
DescriptorDisintegrin and metalloproteinase domain-containing protein 17, MEDI3622 Fab Light Chain, MEDI3622 Fab Heavy Chain, ... (4 entities in total)
Functional Keywordsinhibitor, complex, sheddase, immune system
Biological sourceHomo sapiens (human)
More
Total number of polymer chains3
Total formula weight102211.85
Authors
Slone, C.E.,Maciag, J.J. (deposition date: 2025-04-09, release date: 2025-06-25)
Primary citationMaciag, J.J.,Slone, C.E.,Alnajjar, H.F.,Rich, M.F.,Guion, B.,Ifergan, I.,Blobel, C.P.,Seegar, T.C.M.
Structural insights into the activation and inhibition of the ADAM17-iRhom2 complex.
Proc.Natl.Acad.Sci.USA, 122:e2500732122-e2500732122, 2025
Cited by
PubMed Abstract: The endopeptidase activity of ADAM (a disintegrin and metalloproteinase)-17, the primary processor of several EGFR ligands and tumor necrosis factor-alpha (TNF-α), is essential for proper embryonic development and immune regulation. Dysregulated ADAM17 activity is prevalent in a wide array of human diseases, including cancer, chronic inflammation, and SARS-CoV-2 viral progression. Initially translated as an inactive zymogen, ADAM17 maturation and enzymatic function are tightly regulated by its obligate binding partners, the inactive rhomboid proteins (iRhom) -1 and -2. Here, we present the cryo-EM structure of the ADAM17 zymogen bound to iRhom2. Our findings elucidate the interactions within the ADAM17-iRhom2 complex, the inhibitory mechanisms of the therapeutic MEDI3622 antibody and ADAM17 prodomain, and the previously unknown role of a membrane-proximal cytoplasmic reentry loop of iRhom2 involved in the mechanism of activation. Importantly, we perform cellular assays to validate our structural findings and provide further insights into the functional implications of these interactions, paving the way for developing therapeutic strategies targeting this biomedically critical enzyme complex.
PubMed: 40512800
DOI: 10.1073/pnas.2500732122
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.5 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon